These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25242075)

  • 1. Relationship between expression of Livin and the biological behavior of human oral squamous cell carcinoma.
    Lee DH; Yoon TM; Kim SA; Park YL; Lee KH; Lim SC; Lee JK; Joο YE
    Oncol Rep; 2014 Dec; 32(6):2453-60. PubMed ID: 25242075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Livin and the inhibition of tumor progression by Livin silencing in laryngohypopharyngeal cancer.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    In Vivo; 2014; 28(5):751-9. PubMed ID: 25189886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and prognostic significance of Livin in gastric cancer.
    Chung CY; Park YL; Kim N; Park HC; Park HB; Myung DS; Kim JS; Cho SB; Lee WS; Joo YE
    Oncol Rep; 2013 Nov; 30(5):2520-8. PubMed ID: 24008725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and role of the inhibitor of apoptosis protein livin in chemotherapy sensitivity of ovarian carcinoma.
    Liu X; Wang A; Gao H; Yuan Z; Jiao Y
    Int J Oncol; 2012 Sep; 41(3):1021-8. PubMed ID: 22766624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression of livin at the invasive tumor front of oral squamous cell carcinoma].
    Jiang L; Li X; Bai L; Zhang LJ; Zhang C
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1398-400. PubMed ID: 20584688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
    Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
    Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
    Su L; Wang Y; Xiao M; Lin Y; Yu L
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Livin enhances tumorigenesis by regulating the mitogen-activated protein kinase signaling pathway in human hypopharyngeal squamous cell carcinoma.
    Kim SA; Yoon TM; Lee DH; Lee JK; Park YL; Chung IJ; Joo YE; Lim SC
    Mol Med Rep; 2016 Jul; 14(1):515-20. PubMed ID: 27175933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livin promotes progression of breast cancer through induction of epithelial-mesenchymal transition and activation of AKT signaling.
    Li F; Yin X; Luo X; Li HY; Su X; Wang XY; Chen L; Zheng K; Ren GS
    Cell Signal; 2013 Jun; 25(6):1413-22. PubMed ID: 23524337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of livin in gastric cancer and effect of silencing of the livin gene on apoptosis in gastric cancer cells].
    Liu P; Wang TS; You SH; Ge HM
    Zhonghua Zhong Liu Za Zhi; 2007 Aug; 29(8):570-4. PubMed ID: 18210873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of Livin inhibits growth and invasion of gastric cancer cells through blockade of the MAPK pathway in vitro and in vivo.
    Ou JM; Ye B; Qiu MK; Dai YX; Dong Q; Shen J; Dong P; Wang XF; Liu YB; Quan ZW; Fei ZW
    Int J Oncol; 2014 Jan; 44(1):276-84. PubMed ID: 24220265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Livin mediates tumor cell invasion in the DU-145 cell line via NF-κB.
    Chen F; Yang D; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
    Oncol Rep; 2012 Jun; 27(6):2010-6. PubMed ID: 22427141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference-mediated knockdown of Livin suppresses cell proliferation and invasion and enhances the chemosensitivity to cisplatin in human osteosarcoma cells.
    Li X; Fan S; Li L; Wang L; Fan G; Zhao Q; Li Y
    Int J Oncol; 2013 Jul; 43(1):159-68. PubMed ID: 23632777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livin regulates prostate cancer cell invasion by impacting the NF-κB signaling pathway and the expression of FN and CXCR4.
    Chen F; Yang D; Wang S; Che X; Wang J; Li X; Zhang Z; Chen X; Song X
    IUBMB Life; 2012 Mar; 64(3):274-83. PubMed ID: 22271494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Livin enhances chemoresistance in head and neck squamous cell carcinoma.
    Yoon TM; Kim SA; Lee DH; Lee JK; Park YL; Lee KH; Chung IJ; Joo YE; Lim SC
    Oncol Rep; 2017 Jun; 37(6):3667-3673. PubMed ID: 28440463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of livin gene expression by siRNA leads to growth inhibition and apoptosis induction in human bladder cancer T24 cells.
    Yang D; Song X; Zhang J; Ye L; Wang S; Che X; Wang J; Zhang Z; Wang L
    Biosci Biotechnol Biochem; 2010; 74(5):1039-44. PubMed ID: 20460713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.
    Liu HB; Kong CZ; Zeng Y; Liu XK; Bi JB; Jiang YJ; Han S
    Urol Oncol; 2009; 27(3):277-83. PubMed ID: 18555709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9.
    Sapkota D; Bruland O; Costea DE; Haugen H; Vasstrand EN; Ibrahim SO
    Eur J Cancer; 2011 Mar; 47(4):600-10. PubMed ID: 21074410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Src homology phosphotyrosyl phosphatase 2 (Shp2) expression in oral cancer and knockdown of Shp2 expression inhibit tumor cell viability and invasion in vitro.
    Xie H; Huang S; Li W; Zhao H; Zhang T; Zhang D
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Feb; 117(2):234-42. PubMed ID: 24439919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant expression and potency as a cancer immunotherapy target of inhibitor of apoptosis protein family, Livin/ML-IAP in lung cancer.
    Hariu H; Hirohashi Y; Torigoe T; Asanuma H; Hariu M; Tamura Y; Aketa K; Nabeta C; Nakanishi K; Kamiguchi K; Mano Y; Kitamura H; Kobayashi J; Tsukahara T; Shijubo N; Sato N
    Clin Cancer Res; 2005 Feb; 11(3):1000-9. PubMed ID: 15709165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.